Vaccines,therapeutic clin trials to boost COVID prevention & treatment

The European Commission has launched a call, COVID19 - HERA Incubator, that will mobilize all means and resources necessary to prevent, mitigate and respond to the potential impact of COVID-19 variants.

The European Commission has launched a call, COVID19 - HERA Incubator, that will mobilize all means and resources necessary to prevent, mitigate and respond to the potential impact of COVID-19 variants.
April 13, 2021

The European Commission has launched a call, COVID19 – HERA Incubator (HORIZON-HLTH-2021-CORONA-01), that will mobilize all means and resources necessary to prevent, mitigate and respond to the potential impact of COVID-19 variants.

This specific call aims at supporting activities that enable the conduct of vaccine & therapeutic trials to boost prevention and further inform public health policy and clinical management. Proposals submitted under this expression of interest should aim to further develop promising therapeutic or prophylactic candidates against SARS-CoV-2/COVID-19

Asphalion is actively involved in several European granted H2020 projects consortium as partner, taking care of the regulatory activities during the development of different innovative products. Furthermore, Asphalion is already participating as a Regulatory Partner in different COVID-19 related projects.

In case you need further information please contact us at: h2020@asphalion.com

Search News & Events

  • Filter by category

Share

Related news and events

Medical Device Regulation extended

Following informal contacts with the European Parliament, it is expected that the European
Parliament will vote on the text of the Commission proposal without amendments as its
position at first reading during the plenary session of 13-16 February 2023, through an
urgency procedure and subject to legal-linguistic revision of the text.

Publicación de la AEMPS de nuevas instrucciones para la realización de investigaciones clínicas con productos sanitarios en España

El real decreto sobre productos sanitarios en desarrollo, que sustituirá a los actuales reales decretos de productos sanitarios (Real Decreto 1591/2009) y de productos sanitarios implantables activos (Real Decreto 1616/2009), introduce modificaciones en la legislación nacional de productos sanitarios, con el objetivo de hacer posible la aplicación del Reglamento y desarrollar aquellos aspectos que el mismo deja al desarrollo de la legislación nacional.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting